The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting
- 12 January 2005
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 20 (3) , 251-254
- https://doi.org/10.1007/s00467-004-1613-y
Abstract
We have created a liver-specific igf1 gene-deletion mouse model (LID) with markedly reduced circulating IGF-I levels. They demonstrate that while they have normal growth and development they develop insulin resistance secondary to the elevation of circulating growth hormone. When mated with an acid-labile subunit (ALS) gene-deleted mouse they also show osteopenia suggesting that circulating IGF-I levels play a significant role in bone formation. In a separate transgenic mouse we created a model of severe insulin resistance and type 2 diabetes by the overexpression of a dominant-negative IGF-I receptor in skeletal muscle. In this model we show that lipotoxicity plays a major role in the progression of the disease and is affected by treatment with a fibrate, which reverses the insulin resistance and diabetic state. These models are therefore very useful in studying human physiology and disease states.Keywords
This publication has 12 references indexed in Scilit:
- Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient miceJournal of Clinical Investigation, 2004
- Insulin Resistance in the Liver-Specific IGF-1 Gene-Deleted Mouse Is Abrogated by Deletion of the Acid-Labile Subunit of the IGF-Binding Protein-3 ComplexDiabetes, 2003
- Peroxisome Proliferator–Activated Receptor-α Agonist Treatment in a Transgenic Model of Type 2 Diabetes Reverses the Lipotoxic State and Improves Glucose HomeostasisDiabetes, 2003
- Circulating levels of IGF-1 directly regulate bone growth and densityJournal of Clinical Investigation, 2002
- Circulating levels of IGF-1 directly regulate bone growth and densityJournal of Clinical Investigation, 2002
- Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetesGenes & Development, 2001
- Liver-Specific igf-1 Gene Deletion Leads to Muscle Insulin InsensitivityDiabetes, 2001
- The Somatomedin Hypothesis: 2001Endocrine Reviews, 2001
- Normal growth and development in the absence of hepatic insulin-like growth factor IProceedings of the National Academy of Sciences, 1999
- Somatomedin: Proposed Designation for Sulphation FactorNature, 1972